Completed Omalizumab to Treat Hyper-IgE (Job's) Syndrome NCT00260702 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Genetic Diseases, Inborn, +12 more Locations National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States View Trial Details
